- Filed
- May 5, 2025 12:00 AM ET
- Period of report
- —
Amendment.
Amends a previously filed report.
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2024 · Apr 8, 2025 | 111M sh |
| Shares Diluted | FY 2024 · Dec 31, 2024 | 20.18M sh |
| Shares Diluted | FY 2024 · Dec 31, 2023 | 16.58M sh |
| Capex | FY 2024 · Dec 31, 2024 | $42.67K |
| Capex restated | FY 2024 · Dec 31, 2023 | $0 |
| Operating Cash Flow | FY 2024 · Dec 31, 2024 | −$1.72M |
| Operating Cash Flow restated | FY 2024 · Dec 31, 2023 | −$377.3K |
| Stockholders Equity | FY 2024 · Dec 31, 2024 | −$2.55M |
| Stockholders Equity restated | FY 2024 · Dec 31, 2023 | −$515.37K |
| Stockholders Equity restated | FY 2024 · Dec 31, 2022 | $160.85K |
| Current Liabilities | FY 2024 · Dec 31, 2024 | $5M |
| Current Liabilities restated | FY 2024 · Dec 31, 2023 | $1.94M |
| Current Assets restated | FY 2024 · Dec 31, 2024 | $967.28K |
| Current Assets restated | FY 2024 · Dec 31, 2023 | $125.83K |
| Total Assets | FY 2024 · Dec 31, 2024 | $2.45M |
| Total Assets restated | FY 2024 · Dec 31, 2023 | $1.43M |
| Eps Diluted | FY 2024 · Dec 31, 2024 | −$0.15 |
| Eps Diluted | FY 2024 · Dec 31, 2023 | −$0.11 |
| Sga Expense restated | FY 2024 · Dec 31, 2024 | $1.35M |
| Sga Expense restated | FY 2024 · Dec 31, 2023 | $886.82K |
| Net Income | FY 2024 · Dec 31, 2024 | −$3.08M |
| Net Income restated | FY 2024 · Dec 31, 2023 | −$1.74M |
| Operating Income restated | FY 2024 · Dec 31, 2024 | −$1.98M |
| Operating Income restated | FY 2024 · Dec 31, 2023 | −$1.57M |
| Gross Profit restated | FY 2024 · Dec 31, 2024 | −$40.56K |
| Gross Profit restated | FY 2024 · Dec 31, 2023 | −$126.46K |
| Cost Of Revenue restated | FY 2024 · Dec 31, 2024 | $2.61M |
| Cost Of Revenue | FY 2024 · Dec 31, 2023 | $2.93M |
| Revenue restated | FY 2024 · Dec 31, 2024 | $2.57M |
| Revenue restated | FY 2024 · Dec 31, 2023 | $2.8M |